EUDAMED Connector

Onboard, transform, and validate device data to automate M2M submissions to EUDAMED.

EUDAMED Connector
ATRIFY Connector

Transform, validate, and synchronize GDSN-compliant product data with your trading partners via atrify.

ATRIFY Connector
Success Story
Success Story

B. Braun implemented Innovit’s EUDAMED Connector to automate UDI submissions, enabling data onboarding from SAP, native EUDAMED-compliant data validation, and secure machine-to-machine data exchange with EUDAMED.

Featured Article
EUDAMED Compliance Guide for Device Manufacturers

Get practical, step-by-step guidance that translates regulatory and database requirements into actionable tasks that help you prepare, validate, and submit compliant device data to EUDAMED.

Featured Article
Celebrating 25 years of Bringing quality to master data!

Read a special note from Bang Chau reflecting on 25 years of bringing quality to master data, celebrating our journey, milestones, and continued commitment to data excellence in healthcare.

Guide

AusUDID Compliance Guide for Device Manufacturers and Sponsors

How to Prepare for AusUDID Submission

Purpose and Scope of This Guide

Australia has introduced a national Unique Device Identification framework to improve the identification, traceability, and management of medical devices throughout the healthcare system. At the center of the framework is the Australian Unique Device Identification Database, or AusUDID, which is maintained by the Therapeutic Goods Administration and stores UDI-DIs and associated information for medical devices supplied in Australia.

The Australian UDI framework introduces obligations that extend beyond assigning an identifier to a device. Manufacturers and Australian sponsors must coordinate the allocation of identifiers, application of UDI carriers, preparation of device data, linkage of UDI records to relevant Australian Register of Therapeutic Goods inclusions, and ongoing maintenance of published information. These responsibilities are shared, but they are not identical: manufacturers generally control the device and identifier data, while sponsors remain responsible for ensuring that devices supplied in Australia comply with applicable regulatory requirements and that AusUDID records contain the required Australian sponsor information.

Australia is implementing UDI requirements progressively according to device risk. Mandatory compliance began on July 1, 2026, for Class III and Class IIb medical devices, followed by later dates for Class IIa, Class Is, and IVD devices. This phased approach gives manufacturers and sponsors time to assess scope, prepare device data, establish submission processes, and prepare compliant labeling and database records.

This guide provides practical guidance for preparing, submitting, validating, and maintaining UDI records in the AusUDID. It also explains the governance, quality, security, and operational controls required to support sustainable compliance across the medical device lifecycle.

This guide is intended for medical device and IVD manufacturers, Australian sponsors, and cross-functional teams responsible for AusUDID compliance.

It is particularly relevant to:

  • Regulatory Affairs and Regulatory Operations teams managing UDI data, submissions, ARTG linkage, and lifecycle updates
  • Australian sponsors responsible for sponsor-specific information and record maintenance
  • Quality Assurance teams supporting validation, data integrity, change control, and audit readiness
  • IT, Integration, PIM, MDM, and Data Governance teams supporting source data, connectivity, security, and governance
  • Regulatory and Quality leaders assessing organizational readiness for Australia’s UDI requirements

What This Guide Covers

This guide focuses on the preparation, submission, and ongoing maintenance of device information in the AusUDID, including:

  • Australia’s phased UDI requirements and device scope
  • Manufacturer and sponsor responsibilities
  • Core UDI identifiers and AusUDID data elements
  • ARTG linkage, user access, and submission methods
  • Data preparation, validation, submission, and error handling
  • UDI Triggers, lifecycle updates, and record maintenance
  • System validation, security, governance, and audit readiness

What This Guide Doesn’t Cover

This guide does not replace applicable legislation or formal TGA guidance. It does not provide detailed guidance on:

  • Physical labeling and barcode design
  • Conformity assessment or ARTG inclusion applications
  • Technical documentation, clinical evidence, or performance evaluation
  • Post-market incident reporting and recalls
  • Legal interpretation of Australian therapeutic goods legislation
  • UDI requirements outside Australia

Manufacturers and sponsors should refer to current TGA guidance, the Australian UDI Data Dictionary, and applicable legislation when making device-specific compliance decisions.

Understanding Australia’s UDI Framework and the AusUDID

Australia’s UDI framework establishes a standardized method for identifying medical devices and connecting those identifiers to trusted regulatory and product information. Its objectives include improving traceability, supporting faster identification of affected devices during recalls and safety actions, reducing inconsistent product data, and enabling better information exchange across the healthcare system.

The AusUDID is the national database that stores UDI-DIs and related device information for medical devices supplied in Australia. UDI records must be linked to relevant ARTG inclusions to appear in the public AusUDID and satisfy applicable database obligations. Patients, consumers, healthcare professionals, and clinical quality registries can access published information without charge. The database does not store patient information or UDI Production Identifiers.

UDI requirements are being introduced progressively by device classification.

Class I non-measuring, non-sterile devices and Class Im measuring devices are not subject to mandatory UDI requirements. Certain Class 1 IVD instruments and software are nevertheless in scope, while other exemptions apply to specified device types.

The ARTG and AusUDID serve different but connected purposes. An ARTG inclusion authorizes the supply of a category of medical devices in Australia, while an AusUDID record contains the identifier and detailed data for a specific device model or version.

A UDI record must be linked to at least one relevant ARTG inclusion before its information can appear publicly and fulfil the database component of the UDI requirements. One ARTG inclusion may therefore be associated with multiple UDI records, depending on the devices covered by that inclusion.

Key Takeaway

AusUDID is not simply a medical device database. It connects device identification, ARTG inclusion information, manufacturer/sponsor data, and ongoing lifecycle maintenance within a single Australian regulatory framework.

Determining Scope and Understanding UDI Identifiers

Before preparing AusUDID submissions, manufacturers and sponsors must determine whether their devices are in scope, which identifiers apply, and whether any device-specific exemptions or additional requirements must be considered.

Medical devices supplied in Australia that require ARTG inclusion generally must comply with UDI requirements if their classification is in scope and no exemption applies.

The principal device classes subject to UDI are:

  • Class Is
  • Class IIa
  • Class IIb
  • Class III
  • Class 2, Class 3, and Class 4 IVDs
  • Certain Class 1 IVD instruments and software

Devices outside mandatory scope include Class I non-measuring, non-sterile devices, Class Im devices, in-house IVDs, custom-made devices, certain low-volume patient-matched devices, devices supplied under specified access schemes, and other listed exemptions. Devices intended strictly for export and not supplied in Australia are also outside the Australian UDI requirements.

Specific rules may apply to reusable devices, software, implantable devices, systems and procedure packs, accessories, replacement parts, and devices supplied in surgical loan kits. Manufacturers should assess these product types individually rather than applying a single portfolio-wide assumption.

TThe Australian framework requires several related identifiers:

  • UDI-DI: The fixed identifier representing a specific device model or version.
  • UDI-PI: The variable production information associated with a manufacturing instance, such as lot, batch, serial number, manufacturing date, or expiry date.
  • Package DI: An identifier assigned to an applicable higher level of packaging.
  • Unit of Use DI: An identifier used where an individual device does not carry a UDI at the unit-of-use level but must still be identified.
  • Direct Marking DI: An identifier used where UDI information must be directly marked on the device.

The UDI-DI and associated device data are stored in the AusUDID. The UDI-PI is not stored in the database because it changes between production runs.

Manufacturers must obtain identifiers through an issuing agency recognized by the TGA and follow the applicable coding standard. The selected issuing agency determines the structure and allocation rules for identifiers, while Australian regulations and the AusUDID define how those identifiers must be used and reported.

The TGA recognizes the following issuing agencies:

  • GS1
  • HIBCC
  • ICCBBA

Each applicable higher level of packaging may require its own Package DI. Packaging relationships must be represented accurately so that the AusUDID reflects how devices are supplied and identified in practice.

When a device has several identifiers from different issuing agencies, the AusUDID can also capture secondary device identifiers. However, a clear primary identifier must be established for the UDI record.

Key Takeaway

Scope assessment should occur at the individual device and configuration level. Classification alone is not sufficient; manufacturers must also consider device type, packaging, direct marking, intended supply arrangements, and exemptions.

Sponsor and Manufacturer Responsibilities

A distinctive feature of Australia’s UDI framework is the shared responsibility between the legal manufacturer and the Australian sponsor. Successful compliance requires both parties to define who will prepare, submit, review, and maintain each category of AusUDID data.

Manufacturers are responsible for activities that relate directly to the device and its identification, including:

  • Selecting a TGA-recognized issuing agency
  • Allocating applicable UDI-DIs, UDI-PIs, Package DIs, Unit of Use DIs, and Direct Marking DIs
  • Applying compliant UDI carriers to devices and packaging
  • Determining when a product change constitutes a UDI Trigger
  • Allocating new identifiers when required
  • Providing accurate device data for submission to the AusUDID
  • Agreeing on data exchange and submission responsibilities with Australian sponsors
  • Demonstrating compliance with applicable Essential Principles when requested

The sponsor remains responsible for the devices it supplies in Australia. Key responsibilities include:

  • Confirming that the manufacturer has met applicable UDI requirements
  • Confirming that required identifiers have been allocated
  • Ensuring that UDI carrier formats are appropriate
  • Agreeing on submission and data-sharing arrangements with the manufacturer
  • Ensuring the accuracy and currency of AusUDID information
  • Linking UDI records to relevant ARTG inclusions
  • Adding sponsor-specific data
  • Maintaining required records
  • Ensuring compliance with the Essential Principles

A sponsor remains accountable even when a manufacturer, agent, software provider, or other third party submits records on its behalf.

AusUDID data is divided into device data and sponsor-specific data.

Device data is normally provided by the manufacturer and may include:

  • Primary DI
  • Model or version
  • Sterilization method
  • Clinical size
  • Storage and handling information
  • Device characteristics
  • Packaging relationships

Sponsor data can be added only by a sponsor and may include:

  • ARTG ID
  • Catalog number
  • Sponsor commercial distribution end date
  • Package commercial distribution end date
  • Supporting documents such as Instructions for Use or Patient Information Leaflets

Manufacturers submitting directly to AusUDID cannot add sponsor-only data or link the record to an ARTG inclusion.only data or link the record to an ARTG inclusion.

A device may be supplied in Australia by more than one sponsor. In these circumstances, the device information may be shared within one UDI record, while each sponsor adds and maintains its own sponsor-specific details and ARTG linkage.

This arrangement requires clear governance because a manufacturer’s device-level changes can affect every Australian sponsor associated with the record.

Key Takeaway

Responsibility can be delegated operationally, but regulatory accountability remains with the manufacturer and sponsor. Streamlined data-sharing, approval, and maintenance arrangements are essential.

Preparing Device Data for AusUDID Submission

Accurate AusUDID submissions depend on complete, reliable, and well-governed device data. Device information is often distributed across manufacturer and sponsor systems, requiring both organizations to coordinate data collection and validation before submission.

The Australian UDI Data Dictionary is the authoritative reference for AusUDID data elements. It defines:

  • Data element names
  • Descriptions
  • Permitted values
  • Mandatory or conditional status
  • Edit rules
  • UDI Trigger rules
  • Other technical metadata

The TGA updates the dictionary through published versions, meaning organizations must monitor changes and assess their impact on data models, validation rules, templates, and integrations.ing organizations must monitor changes and assess their impact on data models, validation rules, templates, and integrations.

AusUDID data elements fall into three broad categories:

  • Mandatory: Required in every applicable UDI record.
  • Optional: Not required, but often useful to healthcare users and strongly recommended when available.
  • Conditionally mandatory: Required only when specified conditions apply.

For example, the Primary DI and Model/Version are mandatory. A Unit of Use DI, Direct Marking DI, or Package DI may become mandatory based on devrking DI, or Package DI may become mandatory based on device count, marking arrangements, or packaging configuration.

Relevant device data may originate from multiple sources. For example:

The authoritative source should be defined for each data element to avoid conflicting values between manufacturer and sponsor systems.

A readiness assessment should identify:

  • Missing mandatory and conditionally mandatory attributes
  • Invalid code values
  • Identifier formatting problems
  • Incomplete packaging hierarchies
  • Devices not mapped to the correct ARTG inclusion
  • Inconsistent catalog numbers or commercial information
  • Duplicate records
  • Missing manufacturer-to-sponsor ownership assignments
  • Australian data elements not maintained for other jurisdictions

Manufacturers with existing GUDID or other international UDI data should not assume that the same dataset can be submitted unchanged. Australian permitted values, conditional rules, sponsor fields, ARTG linkage, and UDI Trigger definitions must be assessed separately.

Key Takeaway

AusUDID data preparation is a cross-organizational activity. Manufacturers control much of the device data, while sponsors control critical Australian regulatory and commercial fields. Both datasets must be combined and validated before the record can meet compliance obligations.

AusUDID Access and Submission Methods

AusUDID provides separate Production and Pre-Production environments and supports four submission methods. Access and capabilities depend on whether the organization is registered as a sponsor, manufacturer, or both, and on the user’s TGA Business Services role.

The Production environment is the live AusUDID. Records published there can support compliance and may be made available to the public once linked to an ARTG inclusion.

The Pre-Production environment is used for familiarization, functionality testing, and submission testing. Data entered into Pre-Production does not transfer to Production and does not satisfy UDI compliance obligations. HL7 SPL users must complete required Pre-Production testing before making live submissions.

AusUDID capabilities depend on the organization’s relationship to the device and the user’s TGA Business Services role.

Relevant organization types include:

  • Sponsor
  • Manufacturer
  • Sponsor and manufacturer

Relevant TBS system roles include:

  • Administrator – Manages user access levels and permissions within the organization’s TBS portal.
  • Drafter – Creates and edits draft UDI records inside the database.
  • Submitter – Formally validates and publishes UDI records to the system.
  • Financial – Handles fee-related or administrative accounting aspects tied to portal administration.

A Drafter or Submitter can prepare records through the portal, while publication requires the Submitter role. Manufacturers can submit device data but cannot add sponsor-only information or ARTG links.

The AusUDID portal supports manual creation and maintenance of one record at a time.

It is best suited to:

  • Organizations with few records
  • Infrequent submissions
  • New users learning the database
  • Individual corrections or updates

The portal requires a TBS login. Users need a Drafter or Submitter role to prepare records and a Submitter role to publish them.role to prepare records and a Submitter role to publish them.

The Microsoft Excel bulk template supports submission of up to 200 records in one upload. It is suitable for low-to-medium submission volumes and separates information into worksheets covering core device data, sponsor data, secondary identifiers, and other record components.

Manufacturers and sponsors may collaborate on preparation: the manufacturer can populate device information, while the sponsor completes sponsor-specific fields and submits the final file.

HL7 Structured Product Labeling supports high-volume machine-to-machine submission using XML-based messages. Sponsors, manufacturers, and authorized agents may use this method.

HL7 SPL is suitable for:

  • Large device portfolios
  • Frequent new records and updates
  • Organizations already familiar with SPL
  • Automated integration from PIM, MDM, RIM, or regulatory submission platforms
  • Third-party data providers submitting on behalf of sponsors

A TBS account is not required for the system transmitting the HL7 SPL message, but a TBS user must generate the credentials used for the submission. Requiresed for the submission. Required testing must be completed in Pre-Production.

Organizations that already use GS1 Australia’s National Product Catalogue may submit UDI records through the NPC. This approach is intended for medium-to-high record volumes and can reduce duplicate data maintenance when product information is already governed and syndicated through the NPC.

The NPC is one of the four supported methods; its availability and service performance are managed separately from the TGA.

Key Takeaway

The most appropriate submission method depends on portfolio size, submission frequency, data maturity, sponsor-manufacturer operating model, and integration strategy. Organizations should select a method that supports both initial compliance and ongoing maintenance.

Best-Practice AusUDID Submission Process

A controlled submission process ensures that UDI information is prepared, reviewed, published, linked to the ARTG, and maintained consistently. The same governance principles apply regardless of whether records are submitted manually, through bulk upload, via HL7 SPL, or through the NPC.

For each device, determine:

  • Whether it is in scope
  • Its classification
  • Its applicable mandatory date
  • Whether an exemption or transitional arrangement applies
  • Whether device-specific UDI rules apply

The manufacturer should allocate the applicable:

  • Primary UDI-DI
  • UDI-PI structure
  • Package DIs
  • Unit of Use DI
  • Direct Marking DI

Identifier allocation should follow the recognized issuing agency’s rules and the Australian UDI requirements.

Compile the mandatory, optional, and conditionally mandatory data defined in the current Australian UDI Data Dictionary.

The dataset should reflect the approved device, label, packaging hierarchy, sterilization status, clinical characteristics, and other relevant information.

The Australian sponsor should add or verify:

  • Relevant ARTG ID
  • Catalog number
  • Commercial distribution information
  • Sponsor-specific packaging data
  • Applicable supporting documents

When a manufacturer submits the device record first, the sponsor may subsequently add its information using tord first, the sponsor may subsequently add its information using the Sponsor Link Template or available AusUDID functionality.

Before final submission, validate:

  • Required fields
  • Permitted values
  • UDI formats
  • Issuing agency information
  • Packaging relationships
  • Conditional rules
  • Sponsor data
  • ARTG linkage
  • Technical message or template structure

Manufacturers and sponsors should apply documented review and approval workflows. The final record should be checked against approved labels, technical documentation, ARTG information, and agreed-upon source systems.

Use Pre-Production to test:

  • User roles
  • Portal workflows
  • Bulk upload files
  • HL7 SPL messages
  • Validation responses
  • Sponsor-manufacturer handoffs
  • Record updates and corrections

HL7 SPL testing requirements rements must be completed before live submission.

Submit the approved record using the selected method. Publication must be performed by an appropriately authorized user or system credential.

Verify that the record:

  • Was accepted
  • Is linked to at least one relevant ARTG inclusion
  • Contains the correct sponsor details
  • Is visible as expected
  • Has no unresolved data validation or workflow issues

Establish processes for ongoing device data maintenance in AusUDID including:

  • Corrections
  • Non-trigger updates
  • New UDI records following UDI Triggers
  • Commercial distribution end dates
  • Packaging updates
  • Sponsor changes
  • ARTG changes
  • Device discontinuation

Key Takeaway

A successful AusUDID submission process extends from scope assessment through lifecycle maintenance. Publication alone does not complete the obligation; records must remain accurate and linked to the correct Australian sponsor and ARTG inclusion.

Data Validation, Corrections, UDI Triggers, and Submission Monitoring

AusUDID records are subject to data validation rules defined by the database and Australian UDI Data Dictionary. Organizations must distinguish between corrections, permitted updates, and changes that require a new UDI-DI and a new UDI record.

Validation should confirm:

  • Mandatory data is present
  • Conditional fields are supplied when required
  • Values conform to the Data Dictionary
  • Device and sponsor data are consistent
  • Packaging relationships are complete
  • ARTG information is valid
  • Identifier structures match the issuing agency
  • Uploaded templates or HL7 SPL messages meet technical requirements

A correction addresses an error in an existing record, such as incorrect data entry. The AusUDID requires a reason for corrections, and use of this functionality may be monitored by the TGA.

A non-trigger update changes information that is permitted to be edited without creating a new UDI-DI.

A UDI Trigger change cannot be handled by editing the existing trigger field. The manufacturer must allocate a new UDI-DI, and a new UDI record must be created.

Australian UDI Trigger fields include changes to attributes such as:

  • Primary DI or issuing agency
  • Device count
  • Direct Marked DI
  • Brand name
  • Model or version
  • Software status
  • Kit status
  • MRI safety status
  • Single-use status
  • Restricted number of reuses
  • Latex status
  • Sterile packaging status
  • Sterilization-before-use status
  • Certain clinical size information

A new UDI-DI may also be required when changes affect safety or performance, create a new model or major software version, rsion, or meet the issuing agency’s identifier-change rules.

When a trigger occurs, the manufacturer should:

  • Allocate a new UDI-DI
  • Apply the new identifier to the device
  • Allocate new Package DIs when applicable
  • Notify affected sponsors
  • Provide updated device data

The sponsor should:

  • Create or ensure creation of a new UDI record
  • Link the new record to the relevant ARTG inclusion
  • Include the Previous DI when possible
  • Add sponsor-specific information
  • Update commercial and lifecycle records

Organizations should monitor:

  • Submitted records
  • Data Validation outcomes
  • Rejected or incomplete records
  • Sponsor linkage status
  • ARTG linkage
  • Records awaiting review or publication
  • Corrections and resubmissions
  • UDI Trigger changes
  • Commercial distribution end dates

UDI records generally should not be deleted merely because supply has ended. Instead, the sponsor should update the commercial distribution end date. Deletion is generally limited to test records, duplicates, or records created accidentally, and deleted Production records may be reviewed by the TGA.

Key Takeaway

Lifecycle management for device data starts with correctly classifying each change. Editing a UDI Trigger field is not permitted as an ordinary update; it requires a new identifier and record.

System Quality, Validation, and Security Requirements

AusUDID submissions are part of a regulatory compliance process. Systems used to prepare, review, approve, and transmit records should therefore support appropriate quality, security, and data integrity controls.

UDI information should remain:

  • Attributable to an authorized source
  • Complete and accurate
  • Consistent between source systems, labels, ARTG records, and AusUDID
  • Protected from unauthorized alteration
  • Available throughout the required retention period
  • Traceable through corrections and updates

Manufacturers and sponsors should apply risk-based validation to systems that support critical UDI compliance processes. GAMP 5 principles can be used to scale validation according to system risk, configuration, automation, and potential impact on device identification or regulatory compliance.

Validation activities may include:

  • User requirements
  • Configuration specifications
  • Risk assessments
  • Functional and integration testing
  • Data migration verification
  • Validation of bulk templates or HL7 SPL interfaces
  • User acceptance testing
  • Traceability between requirements and test evidence
  • Controlled release and change management

Although Australia’s UDI rules do not make 21 CFR Part 11 or EU Annex 11 direct AusUDID requirements, global manufacturers may use submission systems within quality environments governed by these expectations.

Relevant controls include:

  • Unique user identification
  • Role-based access
  • Controlled approvals with electronic signatures
  • Audit trails
  • Record retention
  • Protection against unauthorized modification

Systems supporting AusUDID compliance should provide:

  • Role-based access control
  • Secure credential management
  • Backup and disaster recovery
  • Security incident response
  • Periodic access review
  • Third-party risk management

A sponsor may authorize a manufacturer, agent, integration provider, or other third party to submit data, but the sponsor remains responsible for the records submitted on its behalf. Third-party arrangements should therefore define security, validation, service continuity, error management, record ownership, and regulatory responsibilities.

Key Takeaway

Secure, reliable and validated systems must support the manufacturer’s and sponsor’s quality responsibilities for UDI compliance.

Best Practices for Successful AusUDID Compliance

Manufacturers and sponsors should be able to demonstrate how each device record was prepared, validated, approved, submitted, linked to the ARTG, and maintained.

Relevant evidence may include:

  • Approved device and packaging data
  • Submission files or messages
  • AusUDID data validation responses
  • Publication confirmations
  • ARTG linkage records
  • Data approval
  • System validation documentation
  • Change control records

Internal reviews should assess:

  • Devices in scope and applicable dates
  • Compliance of device and package identifiers
  • Accuracy of AusUDID records
  • ARTG linkage
  • Sponsor data
  • User roles and access
  • Data approval and submission procedures
  • Management of corrections
  • UDI Trigger decisions
  • Third-party provider controls
  • Data retention and audit trails
  • Timeliness of device lifecycle updates

When a device cannot comply with applicable UDI-related Essential Principles, the Australian sponsor may need to seek TGA consent to import or supply the noncompliant device. A streamlined UDI Consent to Supply process commenced alongside mandatory high-risk requirements on July 1, 2026. This should be treated as an exception process rather than a substitute for timely compliance planning.

Manufacturers and sponsors should:

  • Begin scope and data assessments before the applicable compliance date
  • Confirm responsibilities through documented agreements
  • Use the current Australian UDI Data Dictionary
  • Establish authoritative sources for every data element
  • Test submission methods in Pre-Production
  • Validate records before publication
  • Confirm ARTG linkage after submission
  • Monitor validation results and outstanding actions
  • Embed UDI Trigger assessment into product change control
  • Maintain secure, validated, and auditable systems
  • Review regulatory updates and Data Dictionary revisions
  • Measure data quality and submission performance
  • Treat AusUDID as an ongoing business process rather than a one-time project

Key Takeaway

Audit readiness is achieved through reliable evidence and repeatable processes. Organizations that can reconstruct the full history of a UDI record—from identifier allocation through every subsequent change—are better positioned to demonstrate sustained compliance.

Conclusion

Australia’s UDI framework creates a common foundation for identifying medical devices, improving traceability, strengthening post-market safety activities, and making trusted device information more accessible across the healthcare system. For manufacturers and Australian sponsors, however, compliance requires considerably more than assigning a UDI-DI or publishing an AusUDID record.

Successful implementation depends on correctly determining scope, allocating the required identifiers, applying compliant UDI carriers, preparing high-quality device and sponsor data, linking records to the appropriate ARTG inclusions, and maintaining those records throughout the commercial life of the device. It also requires a clear division of responsibilities between manufacturers and sponsors, particularly when devices are supplied by multiple sponsors or submitted through third-party systems.

The phased implementation schedule provides organizations with an opportunity to establish these capabilities progressively, but the work required should not be underestimated. Data remediation, packaging hierarchy management, manufacturer-sponsor coordination, integration, validation, and lifecycle governance can require substantial preparation—particularly for large or complex product portfolios.

Organizations that embed UDI requirements into product development, labeling, master data quality, and change control processes will be better positioned to maintain AusUDID compliance over time. By combining trusted product data, controlled workflows, secure and validated systems, and continuous monitoring, manufacturers and sponsors can turn AusUDID submissions from a deadline-driven activity into a sustainable regulatory compliance capability.

ACCESS NOW

View the Full Content

Fill out the form below to gain access to the full content.

Share This Content

Explore More

Continue exploring related content and deepen your understanding

Understanding TGA's Medical Device Regulations for UDI in Australia
Insight

Understanding Australia’s UDI Framework and TGA Requirements

RA Evaluating UDI Solution
eBook

For Regulatory Affairs – What To Know About Innovit’s UDI Solution

AUSUDID Connector Datasheet
Datasheet

Innovit AUSUDID Connector

Ready to Simplify Your AusUDID Compliance?

Streamline TGA UDI submissions, improve data quality, and ensure faster regulatory compliance.